The best time to get into a stock is when it's being ignored and no one else is buying. As long as the company is good (pretty obvious that Clinuvel is one of the best run and highest quality ASX stocks under a billion dollar market cap) this will be reversed. Just need a big enough catalyst, and the market will finally price in not only that catalyst but everything it had previously ignored. Vitiligo should surely be a big enough catalyst, so hopefully we get recruitment wrapped up quick and the phase 3 readout soon after.
IMO we are due for a rerate to the all time highs and higher, it's really just a matter of when. The company itself has improved significantly in terms of fundamentals since it hit $40 in 2019, now with the possibility of multiple new major clinical indications and the huge cosmetic opportunity so close, in addition to the cashed up balance sheet and strong recurring cash flows, it seems quite ridiculous how cheap this still is.
- Forums
- ASX - By Stock
- CUV
- Ann: CLINUVEL Newsletter III - June 2024
Ann: CLINUVEL Newsletter III - June 2024, page-19
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$15.50 |
Change
-0.160(1.02%) |
Mkt cap ! $773.7M |
Open | High | Low | Value | Volume |
$15.60 | $15.60 | $15.21 | $450.4K | 29.08K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 114 | $15.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.50 | 138 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 139 | 15.470 |
6 | 171 | 15.460 |
6 | 190 | 15.450 |
3 | 141 | 15.440 |
3 | 165 | 15.430 |
Price($) | Vol. | No. |
---|---|---|
15.500 | 45 | 5 |
15.510 | 165 | 5 |
15.520 | 242 | 6 |
15.530 | 76 | 2 |
15.540 | 424 | 2 |
Last trade - 15.28pm 03/09/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |